These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25109959)

  • 1. Approaches for measuring signalling plasticity in the context of resistance to targeted cancer therapies.
    Wilkes EH; Casado P; Cutillas PR
    Biochem Soc Trans; 2014 Aug; 42(4):791-7. PubMed ID: 25109959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of acquired resistance to targeted cancer therapies.
    Lackner MR; Wilson TR; Settleman J
    Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of feedback in signal transduction for targeted therapies.
    Klinger B; Blüthgen N
    Biochem Soc Trans; 2014 Aug; 42(4):770-5. PubMed ID: 25109956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic alterations as the basis for resistance to targeted therapies.
    Blair BG; Bardelli A; Park BH
    J Pathol; 2014 Jan; 232(2):244-54. PubMed ID: 24114654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive protein and phosphoprotein networks which promote therapeutic sensitivity or acquired resistance.
    Haley J; White FM
    Biochem Soc Trans; 2014 Aug; 42(4):758-64. PubMed ID: 25109954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of drug resistance.
    Longley DB; Johnston PG
    J Pathol; 2005 Jan; 205(2):275-92. PubMed ID: 15641020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-related networks: a help to understand, predict and change malignant transformation.
    Csermely P; Korcsmáros T
    Semin Cancer Biol; 2013 Aug; 23(4):209-12. PubMed ID: 23831276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding resistance to targeted cancer drugs through loss of function genetic screens.
    Berns K; Bernards R
    Drug Resist Updat; 2012 Oct; 15(5-6):268-75. PubMed ID: 23142522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emergence of resistance to targeted cancer therapeutics.
    Mellinghoff IK; Sawyers CL
    Pharmacogenomics; 2002 Sep; 3(5):603-23. PubMed ID: 12223047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feedback regulation in cell signalling: Lessons for cancer therapeutics.
    Nguyen LK; Kholodenko BN
    Semin Cell Dev Biol; 2016 Feb; 50():85-94. PubMed ID: 26481970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex regulation of autophagy in cancer - integrated approaches to discover the networks that hold a double-edged sword.
    Kubisch J; Türei D; Földvári-Nagy L; Dunai ZA; Zsákai L; Varga M; Vellai T; Csermely P; Korcsmáros T
    Semin Cancer Biol; 2013 Aug; 23(4):252-61. PubMed ID: 23810837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive mathematical models of cancer signalling pathways.
    Bachmann J; Raue A; Schilling M; Becker V; Timmer J; Klingmüller U
    J Intern Med; 2012 Feb; 271(2):155-65. PubMed ID: 22142263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance mechanisms in cancer cells: a proteomics perspective.
    Verrills NM; Kavallaris M
    Curr Opin Mol Ther; 2003 Jun; 5(3):258-65. PubMed ID: 12870435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systems biology analysis of autophagy in cancer therapy.
    Shi Z; Li CY; Zhao S; Yu Y; An N; Liu YX; Wu CF; Yue BS; Bao JK
    Cancer Lett; 2013 Sep; 337(2):149-60. PubMed ID: 23791881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer cell survival pathways activated by bone metastasis microenvironment.
    Tenta R; Sotiriou E; Pitulis N; Thyphronitis G; Koutsilieris M
    J Musculoskelet Neuronal Interact; 2005 Jun; 5(2):135-44. PubMed ID: 15951629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
    Wilting RH; Dannenberg JH
    Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards functional phosphoproteomics by mapping differential phosphorylation events in signaling networks.
    de la Fuente van Bentem S; Mentzen WI; de la Fuente A; Hirt H
    Proteomics; 2008 Nov; 8(21):4453-65. PubMed ID: 18972525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ErbB receptors and signaling pathways in cancer.
    Hynes NE; MacDonald G
    Curr Opin Cell Biol; 2009 Apr; 21(2):177-84. PubMed ID: 19208461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, clinical indications, and resistance mechanisms in molecular targeted therapies in cancer.
    Izar B; Rotow J; Gainor J; Clark J; Chabner B
    Pharmacol Rev; 2013; 65(4):1351-95. PubMed ID: 24092887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.